Tech Company Financing Transactions

DNTOX Funding Round

High-Tech Gründerfonds, AQAL Capital and Bool Capital participated in a $1.5 million Seed venture round for DNTOX. The round was announced by the company on 6/19/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Gurlittstraße 53
Düsseldorf, 40223
DE

Phone

+49 211-16786306

Website

www.dntox.de

Email Address

[email protected]

Overview

DNTOX is a German bioanalytical testing laboratory for animal-free screening of chemicals regarding their potential to disturb human brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery uses human cell models and enables artificial intelligence-based chemical screening with in-house developed software.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Ellen Fritsche

        

Co-Founder

Silke Beaucamp

        

Co-Founder

Katharina Koch

        

Browse more venture capital transactions:

Prev: 6/19/2023: DTE venture capital transaction
Next: 6/19/2023: Yellow venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary